TP53 and neoplasm: Further, murine LFS models suggest that within a cohort of p53 heterozygous animals the timing of tumor onset correlates with the prevalence of p53 LOH in tumors [25]; i.e. the trend is that early-onset tumors often have p53 LOH while late tumors often do not.